Has Catherine Warner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $60,913 in general payments to Catherine Warner, MD across 270 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Catherine Warner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Catherine Warner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Catherine Warner, MD

Dermatology · Austell, GANPI 1710220249

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Organon accounts for 68.5% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $50,629, more than ten times the $328 reported in 2019. Among dermatology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,913in general payments, 2019–2025

Across 270 payments — averaging $225.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organon$42K
Sanofi$15K
Regeneron Healthcare Solutions, Inc.$822
Pfizer$764
AbbVie$677
Incyte Corporation$326
plus $2K from 23 others

What the payments were for

Consulting fees$10,87218%
Speaking & faculty fees$34,20056%
Travel & lodging$8,78814%
Food & beverage$6,94911%
Education$1030%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organon	39	$41,722
Sanofi	51	$15,021
Regeneron Healthcare Solutions, Inc.	26	$822
Pfizer	47	$764
AbbVie	31	$677
Incyte Corporation	9	$326
Arcutis Biotherapeutics, Inc.	7	$218
Dermavant Sciences, Inc.	4	$128
Novartis	5	$123
LEO Pharma Inc.	6	$121
Galderma Laboratories, L.p.	7	$113
Promius Pharma LLC	1	$109
E.r. Squibb & Sons, L.L.C.	5	$99
Lilly USA, LLC	4	$95
Verrica Pharmaceuticals Inc.	3	$71
Sun Pharmaceutical Industries Inc.	4	$67
Botanix SB Inc	3	$59
Nobelpharma America, LLC	2	$45
Amgen	2	$42
Boehringer Ingelheim	2	$40
Pierre Fabre Pharmaceuticals, Inc.	2	$38
Krystal Biotech Inc	2	$34
Almirall LLC	2	$34
Mayne Pharma Commercial LLC	1	$31
Springworks Therapeutics, Inc.	1	$31
UCB, Inc.	1	$27
Merz North America, Inc.	1	$20
LNHC, Inc	1	$18
Dermira, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,913 in reported general payments places this provider in the 95th percentile of 345 dermatology providers in Georgia.

See all dermatology providers in Georgia →

Medicare billing

Part B allowed, 2024

$244,340

Medicare patients

830

Services billed

3,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	11	$174,782
Dupixent SyringeDupilumab	13	$46,954
Doxycycline Ir-DrDoxycycline Monohydrate	11	$5,951
Clobetasol Propionate	70	$2,398
Fluocinonide	63	$2,107
Fluorouracil	26	$1,863
Triamcinolone Acetonide	152	$1,384
Ketoconazole	78	$1,253
Tacrolimus	14	$1,239
Doxycycline Hyclate	39	$1,020
Calcipotriene	12	$1,019
Betamethasone Dipropionate	25	$914
Metronidazole	18	$863
Desonide	11	$596
ValacyclovirValacyclovir Hcl	29	$593

Paid to pharmacies, not to this prescriber.

Other dermatology in Austell

Firas HougeirDouglasville$3.1M
David CohenMacon$2.9M
Zakiya RiceAtlanta$1.1M
Joseph PayneAtlanta$711K
Jonathan WeissSnellville$692K
Jamie WeismanAtlanta$620K
Mack RachalAtlanta$260K
Tiffany Clay-RamseyMarietta$207K
Jessica MercerSnellville$183K
Sumayah TaliaferroAtlanta$104K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →